Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan

BACKGROUND: Helicobacter pylori (HP) eradication therapy (HPE) is recommended for patients with unexplained immune thrombocytopenia (ITP); however, the role of HPE in preventing ITP in patients with HP infection remains unclear. Therefore, this study was designed to clarify it. METHODS: This study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Koseki, Mitsuhiro, Sheu, Ming‑Jen, Tsai, Kang-Ting, Ho, Chung-Han, Liu, Hsiao-Hua, Lin, Hung-Jung, Lin, Chien-Liang, Huang, Chien-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907885/
https://www.ncbi.nlm.nih.gov/pubmed/36755235
http://dx.doi.org/10.1186/s12876-023-02664-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907885/
https://www.ncbi.nlm.nih.gov/pubmed/36755235
http://dx.doi.org/10.1186/s12876-023-02664-z

Ejemplares similares